CancerProbe
Latest round
- Series B
Last raised
- Jul 2020
Total raised
- $14M
Investors
- 3
About CancerProbe
Based in Hangzhou, China and established in 2013, CancerProbe operates as a cancer treatment company which focuses on molecular science and early diagnosis of cancer. In 2014, the company obtained the production license from the State Food and Drug Administration. Kevin Sun, the founder of the company, has nearly 25 years of global biological research and development experience at Southwest Medical Center, an American biological institution, and Merck, a world-renowned pharmaceutical company. The company's main products are seven lung cancer-related antibodies.5, CAGE, MAGE A1, SOX2, and GBU4-5. The company's products are used to detect diseases such as cancer. The company’s revenue is generated by providing tumor autoantibody detection platform, MicroRNA platform, ct-DNA platform and other detection products.
Who invested in CancerProbe
3 investors across 2 rounds
See all investors in CancerProbe
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CancerProbe
Who invested in CancerProbe?
CancerProbe has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CancerProbe raised?
CancerProbe has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CancerProbe last raise money?
CancerProbe's most recent round on record is a Series B, in Jul 2020.
What does CancerProbe do?
Based in Hangzhou, China and established in 2013, CancerProbe operates as a cancer treatment company which focuses on molecular science and early diagnosis of cancer.
Where is CancerProbe headquartered?
CancerProbe is headquartered in Hangzhou, China.
Which VCs invest in companies like CancerProbe?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare specialists companies at CancerProbe's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like CancerProbe? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.